Trade Cases
Tariff Relief On Then Off Again
Written by Sandy Williams
March 27, 2020
Relief for importers paying tariffs was just a short-lived illusion. U.S. Customs and Border Protection walked back a decision last week to provide extensions on tariff payments during the coronavirus crisis.
A notice sent on March 20 by CBP stated that it would “approve on a case by case basis additional days for payment of estimated duties, taxes and fees due this emergency.”
Yesterday a new bulletin was issued to “notify the trade community that CBP is no longer accepting requests for additional days for payment.”
CBP said it retains “the right to allow additional days for narrow circumstances including physical inability to file entry or payments, due to technology outages or port closures.” Any payments that were delayed following CBP’s initial announcement were now due to the agency by March 27.
No explanation was given for the change, but it did follow heavy lobbying by organizations that were against any let-up of tariff measures during the pandemic. President Trump also expressed his opposition to tariff relief in statements earlier this week.
On Wednesday, Trump signaled that he may move ahead with tariffs on the European Union. After complaining about regulations on EU medical devices that prevent the import of such devices from the U.S., Trump said the EU has treated the U.S. very unfairly on trade.
“They make it almost impossible for us to have a fair deal,” said Trump. “They know this. They know I am just waiting. We have all of the advantages, by the way. It is going to be easy when I decide to do it [tariffs], but this isn’t the right time to do it. But we have been treated very, very unfairly by the European Union.”
The administration is also considering an executive order prepared by trade advisor Peter Navarro that would require U.S. companies to reshore pharmaceutical and medical device manufacturing. Such a move is opposed the U.S. Chamber of Commerce and the American Chamber of Commerce to the European Union.
“This is the worst possible time to try to dictate how companies should fulfill the needs of hospitals, doctors and patients who are desperately in need of their live-saving products,” said Marjorie Chorlins. Chamber senior vice president for European affairs.
Sandy Williams
Read more from Sandy WilliamsLatest in Trade Cases
Steel industry groups urge House action on LTPF 2.0
Six steel industry organizations have urged House Speaker Mike Johnson to include the Leveling the Playing Field 2.0 Act in any proposed package of legislation against China’s "unfair" trade practices.
CRU: Poor steel margins continue to push down raw material prices
Both iron ore and coking coal prices fell this week because of resistance from buyers. Iron ore prices have continued to fall throughout the past week, following sharp declines in steel prices in China, given no new policy announcement from the ‘Third Plenum’ meeting.
CRU: Imports cause concern in India and Vietnam
High levels of steel imports, especially from China, in recent months are worrying steel makers in India and Vietnam.
Price: The new greenwashing – subsidies to bail out obsolete, excess capacity
The United Kingdom and other countries are using the “green” label to subsidize bailouts of obsolete, inefficient, and excess capacity that should exit the market. US steelmakers have invested billions of dollars in technologies that curb greenhouse gas output. These investments have been market-based and led by EAF producers such as Nucor, Steel Dynamics, and CMC.
AISI, AISC, University of Massachusetts get ~$6.4M EPA grant
The American Iron and Steel Institute (AISI), American Institute of Steel Construction (AISC), and the University of Massachusetts at Amherst have received a grant to enhance emissions reporting for steel construction projects.